Page last updated: 2024-08-23

lonidamine and B-Cell Chronic Lymphocytic Leukemia

lonidamine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, JD; Lagoni, R; Longo, WL; Neville, AJ; O'Keefe, S; Riggs, C; Robins, HI; Schmitt, CL; Steeves, RA1

Trials

1 trial(s) available for lonidamine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.
    International journal of radiation oncology, biology, physics, 1990, Volume: 18, Issue:4

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Cell Line; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; In Vitro Techniques; Indazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Mice; Mice, Inbred AKR; Middle Aged; Pilot Projects; Pyrazoles; Whole-Body Irradiation

1990